| HIV/AIDS: Prevention drug trial disappoints |
 |
 |
 |
 | |||
|
A three-country study has been halted after daily doses of the antiretroviral (ARV) Truvada, used as a pre-exposure prophylaxis (PrEP), failed to prevent HIV infection in the women participating. Read full article here. |
